Leber Congenital Amaurosis (LCA) Market, Global Outlook and Forecast 2023-2028

Report ID: 1372093 | Published Date: Jan 2025 | No. of Page: 62 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Leber Congenital Amaurosis (LCA) Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Leber Congenital Amaurosis (LCA) Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Leber Congenital Amaurosis (LCA) Overall Market Size
    2.1 Global Leber Congenital Amaurosis (LCA) Market Size: 2021 VS 2028
    2.2 Global Leber Congenital Amaurosis (LCA) Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Leber Congenital Amaurosis (LCA) Players in Global Market
    3.2 Top Global Leber Congenital Amaurosis (LCA) Companies Ranked by Revenue
    3.3 Global Leber Congenital Amaurosis (LCA) Revenue by Companies
    3.4 Top 3 and Top 5 Leber Congenital Amaurosis (LCA) Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Leber Congenital Amaurosis (LCA) Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Leber Congenital Amaurosis (LCA) Players in Global Market
        3.6.1 List of Global Tier 1 Leber Congenital Amaurosis (LCA) Companies
        3.6.2 List of Global Tier 2 and Tier 3 Leber Congenital Amaurosis (LCA) Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Leber Congenital Amaurosis (LCA) Market Size Markets, 2021 & 2028
        4.1.2 Infantile Type
        4.1.3 Juvenile Type
    4.2 By Type - Global Leber Congenital Amaurosis (LCA) Revenue & Forecasts
        4.2.1 By Type - Global Leber Congenital Amaurosis (LCA) Revenue, 2017-2022
        4.2.2 By Type - Global Leber Congenital Amaurosis (LCA) Revenue, 2023-2028
        4.2.3 By Type - Global Leber Congenital Amaurosis (LCA) Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Leber Congenital Amaurosis (LCA) Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Eye Clinics
        5.1.4 Medical Research Institute
        5.1.5 Other
    5.2 By Application - Global Leber Congenital Amaurosis (LCA) Revenue & Forecasts
        5.2.1 By Application - Global Leber Congenital Amaurosis (LCA) Revenue, 2017-2022
        5.2.2 By Application - Global Leber Congenital Amaurosis (LCA) Revenue, 2023-2028
        5.2.3 By Application - Global Leber Congenital Amaurosis (LCA) Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Leber Congenital Amaurosis (LCA) Market Size, 2021 & 2028
    6.2 By Region - Global Leber Congenital Amaurosis (LCA) Revenue & Forecasts
        6.2.1 By Region - Global Leber Congenital Amaurosis (LCA) Revenue, 2017-2022
        6.2.2 By Region - Global Leber Congenital Amaurosis (LCA) Revenue, 2023-2028
        6.2.3 By Region - Global Leber Congenital Amaurosis (LCA) Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Leber Congenital Amaurosis (LCA) Revenue, 2017-2028
        6.3.2 US Leber Congenital Amaurosis (LCA) Market Size, 2017-2028
        6.3.3 Canada Leber Congenital Amaurosis (LCA) Market Size, 2017-2028
        6.3.4 Mexico Leber Congenital Amaurosis (LCA) Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Leber Congenital Amaurosis (LCA) Revenue, 2017-2028
        6.4.2 Germany Leber Congenital Amaurosis (LCA) Market Size, 2017-2028
        6.4.3 France Leber Congenital Amaurosis (LCA) Market Size, 2017-2028
        6.4.4 U.K. Leber Congenital Amaurosis (LCA) Market Size, 2017-2028
        6.4.5 Italy Leber Congenital Amaurosis (LCA) Market Size, 2017-2028
        6.4.6 Russia Leber Congenital Amaurosis (LCA) Market Size, 2017-2028
        6.4.7 Nordic Countries Leber Congenital Amaurosis (LCA) Market Size, 2017-2028
        6.4.8 Benelux Leber Congenital Amaurosis (LCA) Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Leber Congenital Amaurosis (LCA) Revenue, 2017-2028
        6.5.2 China Leber Congenital Amaurosis (LCA) Market Size, 2017-2028
        6.5.3 Japan Leber Congenital Amaurosis (LCA) Market Size, 2017-2028
        6.5.4 South Korea Leber Congenital Amaurosis (LCA) Market Size, 2017-2028
        6.5.5 Southeast Asia Leber Congenital Amaurosis (LCA) Market Size, 2017-2028
        6.5.6 India Leber Congenital Amaurosis (LCA) Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Leber Congenital Amaurosis (LCA) Revenue, 2017-2028
        6.6.2 Brazil Leber Congenital Amaurosis (LCA) Market Size, 2017-2028
        6.6.3 Argentina Leber Congenital Amaurosis (LCA) Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Leber Congenital Amaurosis (LCA) Revenue, 2017-2028
        6.7.2 Turkey Leber Congenital Amaurosis (LCA) Market Size, 2017-2028
        6.7.3 Israel Leber Congenital Amaurosis (LCA) Market Size, 2017-2028
        6.7.4 Saudi Arabia Leber Congenital Amaurosis (LCA) Market Size, 2017-2028
        6.7.5 UAE Leber Congenital Amaurosis (LCA) Market Size, 2017-2028
7 Players Profiles
    7.1 AmpliPhi Biosciences
        7.1.1 AmpliPhi Biosciences Corporate Summary
        7.1.2 AmpliPhi Biosciences Business Overview
        7.1.3 AmpliPhi Biosciences Leber Congenital Amaurosis (LCA) Major Product Offerings
        7.1.4 AmpliPhi Biosciences Leber Congenital Amaurosis (LCA) Revenue in Global Market (2017-2022)
        7.1.5 AmpliPhi Biosciences Key News
    7.2 Editas Medicine
        7.2.1 Editas Medicine Corporate Summary
        7.2.2 Editas Medicine Business Overview
        7.2.3 Editas Medicine Leber Congenital Amaurosis (LCA) Major Product Offerings
        7.2.4 Editas Medicine Leber Congenital Amaurosis (LCA) Revenue in Global Market (2017-2022)
        7.2.5 Editas Medicine Key News
    7.3 Novelion Therapeutics
        7.3.1 Novelion Therapeutics Corporate Summary
        7.3.2 Novelion Therapeutics Business Overview
        7.3.3 Novelion Therapeutics Leber Congenital Amaurosis (LCA) Major Product Offerings
        7.3.4 Novelion Therapeutics Leber Congenital Amaurosis (LCA) Revenue in Global Market (2017-2022)
        7.3.5 Novelion Therapeutics Key News
    7.4 ProQR Therapeutics
        7.4.1 ProQR Therapeutics Corporate Summary
        7.4.2 ProQR Therapeutics Business Overview
        7.4.3 ProQR Therapeutics Leber Congenital Amaurosis (LCA) Major Product Offerings
        7.4.4 ProQR Therapeutics Leber Congenital Amaurosis (LCA) Revenue in Global Market (2017-2022)
        7.4.5 ProQR Therapeutics Key News
    7.5 Spark Therapeutics
        7.5.1 Spark Therapeutics Corporate Summary
        7.5.2 Spark Therapeutics Business Overview
        7.5.3 Spark Therapeutics Leber Congenital Amaurosis (LCA) Major Product Offerings
        7.5.4 Spark Therapeutics Leber Congenital Amaurosis (LCA) Revenue in Global Market (2017-2022)
        7.5.5 Spark Therapeutics Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Leber Congenital Amaurosis (LCA) Market Opportunities & Trends in Global Market
    Table 2. Leber Congenital Amaurosis (LCA) Market Drivers in Global Market
    Table 3. Leber Congenital Amaurosis (LCA) Market Restraints in Global Market
    Table 4. Key Players of Leber Congenital Amaurosis (LCA) in Global Market
    Table 5. Top Leber Congenital Amaurosis (LCA) Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Leber Congenital Amaurosis (LCA) Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Leber Congenital Amaurosis (LCA) Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Leber Congenital Amaurosis (LCA) Product Type
    Table 9. List of Global Tier 1 Leber Congenital Amaurosis (LCA) Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Leber Congenital Amaurosis (LCA) Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Leber Congenital Amaurosis (LCA) Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Leber Congenital Amaurosis (LCA) Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Leber Congenital Amaurosis (LCA) Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Leber Congenital Amaurosis (LCA) Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Leber Congenital Amaurosis (LCA) Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Leber Congenital Amaurosis (LCA) Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2023-2028
    Table 30. AmpliPhi Biosciences Corporate Summary
    Table 31. AmpliPhi Biosciences Leber Congenital Amaurosis (LCA) Product Offerings
    Table 32. AmpliPhi Biosciences Leber Congenital Amaurosis (LCA) Revenue (US$, Mn), (2017-2022)
    Table 33. Editas Medicine Corporate Summary
    Table 34. Editas Medicine Leber Congenital Amaurosis (LCA) Product Offerings
    Table 35. Editas Medicine Leber Congenital Amaurosis (LCA) Revenue (US$, Mn), (2017-2022)
    Table 36. Novelion Therapeutics Corporate Summary
    Table 37. Novelion Therapeutics Leber Congenital Amaurosis (LCA) Product Offerings
    Table 38. Novelion Therapeutics Leber Congenital Amaurosis (LCA) Revenue (US$, Mn), (2017-2022)
    Table 39. ProQR Therapeutics Corporate Summary
    Table 40. ProQR Therapeutics Leber Congenital Amaurosis (LCA) Product Offerings
    Table 41. ProQR Therapeutics Leber Congenital Amaurosis (LCA) Revenue (US$, Mn), (2017-2022)
    Table 42. Spark Therapeutics Corporate Summary
    Table 43. Spark Therapeutics Leber Congenital Amaurosis (LCA) Product Offerings
    Table 44. Spark Therapeutics Leber Congenital Amaurosis (LCA) Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Leber Congenital Amaurosis (LCA) Segment by Type in 2021
    Figure 2. Leber Congenital Amaurosis (LCA) Segment by Application in 2021
    Figure 3. Global Leber Congenital Amaurosis (LCA) Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Leber Congenital Amaurosis (LCA) Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Leber Congenital Amaurosis (LCA) Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Leber Congenital Amaurosis (LCA) Revenue in 2021
    Figure 8. By Type - Global Leber Congenital Amaurosis (LCA) Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Leber Congenital Amaurosis (LCA) Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Leber Congenital Amaurosis (LCA) Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Leber Congenital Amaurosis (LCA) Revenue Market Share, 2017-2028
    Figure 12. US Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Leber Congenital Amaurosis (LCA) Revenue Market Share, 2017-2028
    Figure 16. Germany Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2028
    Figure 17. France Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Leber Congenital Amaurosis (LCA) Revenue Market Share, 2017-2028
    Figure 24. China Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2028
    Figure 28. India Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Leber Congenital Amaurosis (LCA) Revenue Market Share, 2017-2028
    Figure 30. Brazil Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Leber Congenital Amaurosis (LCA) Revenue Market Share, 2017-2028
    Figure 33. Turkey Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Leber Congenital Amaurosis (LCA) Revenue, (US$, Mn), 2017-2028
    Figure 37. AmpliPhi Biosciences Leber Congenital Amaurosis (LCA) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Editas Medicine Leber Congenital Amaurosis (LCA) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Novelion Therapeutics Leber Congenital Amaurosis (LCA) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. ProQR Therapeutics Leber Congenital Amaurosis (LCA) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Spark Therapeutics Leber Congenital Amaurosis (LCA) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
62
Frequently Asked Questions
Leber Congenital Amaurosis Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Leber Congenital Amaurosis Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Leber Congenital Amaurosis Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports